Molecular Imaging: Page 73

Flutemetamol-PET useful in beta-amyloid detection

By AuntMinnieEurope.com staff writers

Using the radiopharmaceutical flutemetamol with PET imaging works equally as well as analyzing samples of cerebrospinal fluid to accurately identify early-stage Alzheimer's disease, according to a study published online on 9 September in Neurology.

September 22, 2015

EORTC opens NSCLC clinical trial

By AuntMinnieEurope.com staff writers

The European Organization for Research and Treatment of Cancer (EORTC) has commenced a clinical trial to qualify imaging biomarkers for non-small cell lung cancer (NSCLC).

September 22, 2015

AuntMinnieEurope.com Molecular Imaging Insider

By Wayne Forrest

September 21, 2015

First choice for neuroendocrine tumors: Ga-68 DOTATATE

By Wayne Forrest

PET/CT imaging with radiopharmaceutical gallium-68 (Ga-68) DOTATATE significantly improves whole-body staging of patients with neuroendocrine tumors and should be the modality of choice in these cases, according to German researchers.

September 21, 2015

PET tracer boosts detection of recurrent prostate cancer

By AuntMinnieEurope.com staff writers

A newly developed radiotracer significantly improves the early detection of recurrent prostate cancer, according to research published in the Journal of Nuclear Medicine.

September 17, 2015

Neuroimaging underlines untapped potential of meditation

By Rebekah Moan

Imaging studies have confirmed that meditation can create the same physiological changes in the brain as medication for patients with clinical depression. More research needs to be done, but initial evidence suggests that, instead of medicating, people should try meditating.

September 16, 2015

PET/MRI can be a boon for pediatric cancer patients

By Wayne Forrest

Young pediatric patients may benefit from FDG-PET/MRI for staging and clinically evaluating oncologic disorders, given the hybrid modality's superior soft-tissue contrast and significantly lower radiation dose, according to a study published online August 24 in Investigative Radiology.

September 10, 2015

Lancet: Dementia imaging on cusp of a revolution

By Becky McCall

Imaging is on the "cusp of a revolution," according to a pan-European group of researchers who have studied the mounting evidence supporting the use of different imaging modalities in both early and established dementia. Their personal view was published online by Lancet Neurology.

September 9, 2015

PET/MRI matches PET/CT for recurrent pelvic cancer

By Wayne Forrest

PET/MRI can provide high diagnostic performance for restaging gynecological cancer patients compared with FDG-PET/CT, with only slightly longer scan time and "markedly reduced" radiation exposure, according to a German study published online in the European Journal of Radiology.

September 7, 2015

Eckert & Ziegler appoints Harald Hasselmann to senior post

By AuntMinnieEurope.com staff writers

Isotope technology firm Eckert & Ziegler has appointed Harald Hasselmann, PhD, as its new commercial managing director for sales and finances.

September 6, 2015

U.S. team finds favor with new breast PET unit

By Michael Reiter

A dedicated breast PET unit developed in Spain offers key advantages for breast imaging, according to a U.S. team that has been testing it. The unit offers better resolution than whole-body PET, and it may prove more useful than molecular breast imaging using technetium-99m sestamibi.

August 6, 2015

IBA divests North American subsidiary

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has completed the divestiture of IBA Molecular North America to Illinois Health and Science.

August 2, 2015

Previous Page

Page 73 of 122

Next Page